Clinical Trial

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Active, Not Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatments, alone and in combination, for the treatment of loss-of-control eating and weight following bariatric surgery. This is an acute treatment comparing behavioral weight loss alone or in combination with combination naltrexone/bupropion medication.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2020-10-21; most recent amendment 2026-03-24.
Status change: Recruiting → Active, Not Recruiting 2026-03-24
Status change: Not Yet Recruiting → Recruiting 2021-07-13
Trial Details
NCT Number NCT04599478
Lead Sponsor Yale University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Loss-of-control Eating, Obesity/Overweight
Enrollment 160 participants
Start Date 2021-06-29
Primary Completion 2025-12-12 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27